0607 GMT - Parkway Life REIT seems to be focusing on its Singapore and France portfolios, Maybank Research's Krishna Guha says in a research report. The REIT will probably maintain Singapore portfolio's contribution of over 60% of revenue this year, but near-term priority will likely be deepening its footprint in France following recent acquisitions, the analyst notes. The REIT is expected to explore asset enhancement of its Gleneagles Hospital, while management indicated that new beds will be delivered to its Mount Elizabeth Hospital by 2H, the analyst adds. RHB raises the unit's target price to S$4.20 from S$4.10 to reflect lower borrowing-expense assumptions, with an unchanged buy rating. Units are unchanged at S$3.80. (ronnie.harui@wsj.com)
(END) Dow Jones Newswires
February 25, 2025 01:07 ET (06:07 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.